Navigation Links
Pediatric clinical studies appear prone to bias, Hopkins review shows
Date:7/11/2010

A Johns Hopkins review of nearly 150 randomized controlled trials on children all published in well-regarded medical journals reveals that 40 to 60 percent of the studies either failed to take steps to minimize risk for bias or to at least properly describe those measures.

A report of the team's findings in the August issue of Pediatrics shows that experimental trials sponsored by pharmaceutical or medical-device makers, along with studies that are not registered in a public-access database, had higher risk for bias. So were trials that evaluate the effects of behavioral therapies rather than medication, the report states.

"There are thousands of pediatric trials going on in the world right now and given the risk that comes from distorted findings, we must ensure vigilance in how these studies are designed, conducted and judged," says lead investigator Michael Crocetti, M.D., M.P.H., a pediatrician at Johns Hopkins Children's Center. "Our review is intended as a step in that direction."

Considered the gold standard of medical research, the hallmark of double-blind randomized controlled trials (RTC) is a design that rules out or accounts for actual or potential bias. Results of such studies, when peer-reviewed and published in reputable medical journals, can influence the practice of medicine and patient care. A poorly designed or executed trial can therefore lead researchers to erroneous conclusions about the effectiveness of a drug or a procedure.

Citing the degree of bias risk in the studies they reviewed, the researchers caution pediatricians to be critical readers of studies, even in highly respected journals.

The investigators advise that when reading a report on a trial, pediatricians should not merely look at the bottom line but ask two essential questions: How did the researchers reach the conclusion? and Was their analysis unbiased?

Doctors should apply "smell tests," common sense and skeptical judgment about whether the conclusions fit the data, especially when a study boasts dramatic effects or drastic improvement.

Crocetti and colleagues used the Cochrane Collaboration tool, which assesses risk for bias along six critical aspects including randomization randomly assigning patients to different treatments and masking, the degree to which neither the patient nor the doctor knows which group of patients is receiving an active drug or intervention versus a placebo.

Investigators say that by analyzing each clinical trial along these and four other dimensions, the Cochrane Collaboration can answer what are perhaps the most important questions in medical research: How strong is the causal relationship between the therapy and the effect? and How valid are the conclusions made about the effect of the therapy?

Overall, 41 percent of the 146 trials in the review had improper or poorly described randomization techniques. Industry-funded trials were six times more likely to have high risk for biased randomization than government-funded trials or those funded by nonprofit organizations. And past research, the investigators point out, has shown that industry-funded trials are four to five times more likely to recommend an experimental drug.

"Industry funding is an important driver of medical discovery, but it is critical for investigators involved in such trials to ensure not only that the studies are conceived and executed cautiously with minimum risk for bias, but that any precautions taken against bias are also reported transparently," Crocetti says.

Trial registration and the transparency commitment it reflects is a key step in reducing bias or its influence, the researchers say. In their evaluation, registered trials were nearly 70 percent more likely to have robust randomization than non-registered trials, probably because the registration process itself forces researchers to answer many questions related to trial design and execution. Therefore, the investigators say, registering pediatric trials in the public domain will not only increase transparency but, in the long run, improve the validity of their results. In 2005, the International Committee of Medical Journal Editors called for registering all medical trials involving human subjects with www.ClinicalTrials.gov, a massive public repository of more than 70,000 trials from all over the world. However, less than 60 percent of the pediatric trials in the review were registered there.

The researchers also found that most of the trials (57 percent) either failed to use proper techniques that ensure anonymity or "blinding" to the type of treatment a patient gets, or they failed to clearly describe these techniques. The technique, called allocation concealment, ensures that neither the researcher nor the patient can guess which treatment they will get. The method also helps ensure that the treatment of one subject will not reveal to either scientists or the patients clues about the treatment of the next subject. Trials involving behavioral therapies were four times more likely to have this problem.

Overall, nearly 20 percent of the trials used improper masking techniques to ensure that neither the patient nor the researchers know which treatment went to which patient.

The 146 trials in the review appeared between 2007 and 2008 in the five leading pediatric journals Pediatrics, Pediatric Infectious Diseases, Journal of Pediatrics, Archives of Pediatrics and Adolescent Medicine and the Journal of the American Academy of Child and Adolescent Psychiatry and the three highest-ranked general medical journals JAMA, The New England Journal of Medicine and The Lancet.


'/>"/>

Contact: Ekaterina Pesheva
epeshev1@jhmi.edu
410-516-4996
Johns Hopkins Medical Institutions
Source:Eurekalert

Related medicine news :

1. Molecular signatures may aid fight against pediatric liver disease
2. AAP Offers New Online Pediatric Symptom Checker on HealthyChildren.org
3. International child-health experts to converge on London for Excellence in Pediatrics
4. More Than Half of Pediatricians Make Diagnostic Errors: Survey
5. Pediatricians can help parents recognize overweight preschoolers
6. Sleep-disordered breathing is common but hard to detect in pediatric patients
7. Lemons to Aid Launches Pediatric Kit
8. New national study examines pediatric mobility aid-related injuries
9. Surgical procedure offers new option for pediatric patients with rare cancer in abdomen
10. ENT and Allergy Associates Welcomes Tamekia L. Wakefield, MD, Further Reinforcing its Pediatric Sinus Expertise and Capabilities in Queens
11. Renovations at Riley Hospital for Children will boost pediatric clinical research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2020)... ... 2020 , ... SweetLeaf Stevia Sweetener, the world’s most trusted ... Jorge Cruise to educate consumers on losing weight through better diets with low ... fasting, that is fat burning and boosting your energy, and for reducing added ...
(Date:1/23/2020)... ... 23, 2020 , ... A January 7 article from Good Housekeeping ... The article quotes the president of the American Society of Plastic Surgeons who says ... caused by a person’s facial structure including an undefined jawline, a loss of elasticity ...
(Date:1/23/2020)... , ... January 23, 2020 , ... ... in the state’s life-science industry, presents a panel discussion on gene editing that ... the ChristianaCare John H. Ammon Medical Education Center, the event will provide an ...
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... ... University Hospitals have pledged to take action to improve diagnostic quality and safety ... 60 of the most prominent organizations in healthcare and patient advocacy. , “Diagnostic ...
(Date:1/23/2020)... ... January 23, 2020 , ... Driving ... organizations that operate vehicle fleets in North America and around the globe, has ... published monthly with content accessible on the company’s website. , Developed for fleet ...
Breaking Medicine News(10 mins):
(Date:1/12/2020)... (PRWEB) , ... January 11, 2020 , ... Lerner and ... by supporting the Crohn's and Colitis Foundation’s inaugural Courage Ball. This special evening takes ... Las Vegas Blvd.). Guests are invited to arrive early at 6:00 p.m. for cocktails ...
(Date:1/12/2020)... ... January 12, 2020 , ... FutuRx, Israel’s ... - JJDC, and Takeda Ventures, Inc, operating under a tender from the Israeli ... in collaboration with Ramot at Tel-Aviv University and Glasgow University. , Epeius ...
(Date:1/10/2020)... ... January 10, 2020 , ... Reach Higher at the Common ... high school counselors and award the first annual Excellence in College Counseling Award. ... Extra Yard for Teachers Summit celebration on Saturday, January 11th. In addition to ...
Breaking Medicine Technology: